Single-Center, Double-Blind, Randomized, Placebo-Controlled Study on Efficacy and Safety of rTMS (With Precise Localizat
RecruitingNCT07173920Phase: NAStarted 2025-09-08
Summary
\# Brief Summary (English Version) Tardive Dyskinesia (TD) is a hyperkinetic movement disorder induced by long-term use of dopamine receptor blockers and related drugs. Characterized by involuntary sp
Eligibility
Sex
ALL
Min Age
18 Years
Max Age
65 Years
Locations
Peking University Sixth HosptialBeijing, China
View full study details on ClinicalTrials.gov
clinicaltrials.gov/study/NCT07173920